Management Change/Compensation (Form 8-K)

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On October 16, 2025, Dr. Sharon Hrynkow, a member of the Board of Directors (the "Board") of Forward Industries, Inc. (the "Company"), notified the Company of her decision to resign from the Board, effective immediately. Dr. Hrynkow also resigned from all of her Board committee positions, including her membership on the Audit and Risk Committee, the Compensation Committee, the Nominating and Governance Committee, and the Science and Technology Committee, effective as of the same date. In connection with the resignation, the Company agreed to release Dr. Hrynkow from the lockup executed by the Company and Dr. Hrynkow in connection with the closing of the Company's recent private placement. As of October 20, 2025, Dr. Hrynkow owned 1,486 shares of the Company's common stock and 89,400 exercisable stock options. As of October 20, 2025, the Company had 86,457,465 shares of common stock outstanding.

Dr. Hrynkow's resignation did not result from any disagreement with the Company on any matter relating to the Company's operations, policies or practices.